Search results
Results From The WOW.Com Content Network
Infusion-related reactions, skin reactions, hypomagnesaemia, hypocalcaemia, hypokalaemia, blood clots, interstitial lung disease and aseptic meningitis. Denosumab: SC: RANKL inhibitor. Osteoporosis, including drug- and cancer-related osteoporosis, giant cell tumour of bone and hypercalcaemia of malignancies
Drug price-comparison platform GoodRx recently released an expanded rundown of the 20 most costly drugs in the U.S., based on the list price set by manufacturers — which can be very different ...
In 2010, Alexion priced Soliris as the most expensive drug in the world, [27] at approximately US$409,500 a year in the United States (2010), [27] €430,000 per year for ongoing treatment in the UK, [28] [29] and $500,000 a year in Canada (2014). [30] In 2021, Soliris generated US$1.874 billion in sales. [31] [32]
Rank Drug Trade name Type Main indications Company Sales (USD millions/year) ∆ vs 2014 1 Adalimumab: Humira Biologic Rheumatoid arthritis: AbbVie Inc. 14,012 1,469
Developed by Alexion Pharmaceuticals, Soliris is the most expensive drug in the world, at an average annual cost of $409,500. Soliris itself treats a rare blood disorder called paroxysmal ...
The most expensive drugs on the market are getting more expensive.
Schamberg's disease, (also known as "progressive pigmentary dermatosis of Schamberg", [1] "purpura pigmentosa progressiva" (PPP), [1] and "Schamberg's purpura" [1]) is a chronic discoloration of the skin found in people of all ages, usually only affecting the feet, legs or thighs or a combination. It may occur as a single event or subsequent ...
Drug Manufacturer Indication Avacincaptad pegol: To treat geographic atrophy secondary to age-related macular degeneration [4] Cipaglucosidase alfa: To treat late-onset Pompe disease with miglustat [4] Dabrafenib: Dostarlimab: Eflornithine: Elranatamab: To treat relapsed or refractory multiple myeloma after at least four lines of therapy [4 ...